Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1960 2
1976 2
1985 1
1987 4
1988 2
1989 2
1990 3
1991 1
1992 1
1994 2
1995 3
1996 3
1997 5
1998 4
1999 5
2000 2
2001 5
2002 13
2003 10
2004 10
2005 2
2006 3
2007 2
2008 10
2009 6
2010 3
2011 10
2012 11
2013 18
2014 18
2015 20
2016 34
2017 18
2018 25
2019 24
2020 36
2021 30
2022 42
2023 36
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

397 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Akiyama
Page 1
Visualizing and Modulating Mitophagy for Therapeutic Studies of Neurodegeneration.
Katayama H, Hama H, Nagasawa K, Kurokawa H, Sugiyama M, Ando R, Funata M, Yoshida N, Homma M, Nishimura T, Takahashi M, Ishida Y, Hioki H, Tsujihata Y, Miyawaki A. Katayama H, et al. Cell. 2020 May 28;181(5):1176-1187.e16. doi: 10.1016/j.cell.2020.04.025. Epub 2020 May 20. Cell. 2020. PMID: 32437660 Free article.
Cavefish.
Yamamoto Y. Yamamoto Y. Curr Biol. 2004 Nov 23;14(22):R943. doi: 10.1016/j.cub.2004.10.035. Curr Biol. 2004. PMID: 15556847 Free article. Review. No abstract available.
REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.
Yamashita T, Kudo M, Ikeda K, Izumi N, Tateishi R, Ikeda M, Aikata H, Kawaguchi Y, Wada Y, Numata K, Inaba Y, Kuromatsu R, Kobayashi M, Okusaka T, Tamai T, Kitamura C, Saito K, Haruna K, Okita K, Kumada H. Yamashita T, et al. J Gastroenterol. 2020 Jan;55(1):113-122. doi: 10.1007/s00535-019-01642-1. Epub 2019 Nov 12. J Gastroenterol. 2020. PMID: 31720835 Free PMC article. Clinical Trial.
A Japanese history of the Human Genome Project.
Sakaki Y. Sakaki Y. Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(8):441-458. doi: 10.2183/pjab.95.031. Proc Jpn Acad Ser B Phys Biol Sci. 2019. PMID: 31611500 Free PMC article.
Hideki Kambara made a major contribution by developing a key device for high-speed DNA sequencers, which enabled scientists to construct human genome draft sequences. The RIKEN team led by Yoshiyuki Sakaki (the author) played remarkable roles in the draft sequencing and co …
Hideki Kambara made a major contribution by developing a key device for high-speed DNA sequencers, which enabled scientists to construct hum …
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.
Matsumoto M, Miyakawa Y, Kokame K, Ueda Y, Wada H, Higasa S, Yagi H, Ogawa Y, Sakai K, Miyata T, Morishita E, Fujimura Y; For TTP group of Blood Coagulation Abnormalities Research Study Team, Research on Rare and Intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. Matsumoto M, et al. Int J Hematol. 2023 Nov;118(5):529-546. doi: 10.1007/s12185-023-03657-0. Epub 2023 Sep 10. Int J Hematol. 2023. PMID: 37689812 Free PMC article.
The people behind the papers - Masanori Kawaguchi, Kota Sugiyama and Yoshiyuki Seki.
[No authors listed] [No authors listed] Development. 2019 Jan 28;146(2):dev175851. doi: 10.1242/dev.175851. Development. 2019. PMID: 30692163
We caught up with first authors Masanori Kawaguchi and Kota Sugiyama and their supervisor Yoshiyuki Seki, Associate Professor at Kwansei Gakuin University in Sanda, Japan, to find out more about the story....
We caught up with first authors Masanori Kawaguchi and Kota Sugiyama and their supervisor Yoshiyuki Seki, Associate Professor at Kwan …
The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
Tobisu K. Tobisu K. Jpn J Clin Oncol. 2012 May;42(5):363-7. doi: 10.1093/jjco/hys040. Epub 2012 Mar 26. Jpn J Clin Oncol. 2012. PMID: 22450928 Review.
Now, the UOSG consists of 38 institutions and is gradually overcoming these problems. In 2011, the UOSG changed its group representative to Yoshiyuki Kakehi from Kagawa University and continues to strive to meet the challenge of becoming a more active group. ...
Now, the UOSG consists of 38 institutions and is gradually overcoming these problems. In 2011, the UOSG changed its group representative to …
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.
Tahata Y, Hikita H, Mochida S, Enomoto N, Ido A, Kuroda H, Miki D, Kurosaki M, Hiasa Y, Sakamori R, Kawada N, Yamashita T, Suda G, Yatsuhashi H, Yoshiji H, Kato N, Takami T, Nakao K, Matsuura K, Asahina Y, Itoh Y, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Ueno Y, Akuta N, Miyazaki M, Nozaki Y, Kabayama M, Sobue S, Moriuchi A, Miyaki T, Kodama T, Tatsumi T, Yamada T, Takehara T. Tahata Y, et al. J Gastroenterol. 2023 Dec;58(12):1211-1221. doi: 10.1007/s00535-023-02039-x. Epub 2023 Oct 13. J Gastroenterol. 2023. PMID: 37831182 Free PMC article.
397 results